CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 822 JPY 1.99%
Market Cap: 16.3B JPY
Have any thoughts about
CellSource Co Ltd?
Write Note

CellSource Co Ltd
Investor Relations

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Masayuki Yamakawa M.D.
Executive Chairman & MD
No Bio Available
Mr. Takashi Sawada
President, CEO & Representative Director
No Bio Available
Kaoru Hosoda
COO, GM of Contract Processing Business Division & Executive Officer
No Bio Available
Mr. Masato Tsumamoto
CXO, Chief Transformation Officer & Director
No Bio Available
Tomohiro Iga
GM of Corporate Division & Executive Officer
No Bio Available
Yuta Hayashi
Chief Strategy Officer, GM of Corporate Strategy Division & Executive Officer
No Bio Available

Contacts

Address
TOKYO-TO
Shibuya-Ku
2F, Shibuya Mitake Bldg., 1-19-5, Shibuya
Contacts
+81364555308.0
www.cellsource.co.jp
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.